InnoPharmax, Inc. engages in the development and commercialization of pharmaceutical products for the treatment of oncology and specialty. Its product categories include anti-infection agents, contrast agents, oncology agents, immunological agents, and drugs for rare diseases. The company was founded on October 27, 2005 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company